New Frontiers in the Treatment of Rectal Cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Innovative therapies improve survival and quality of life in rectal cancer, suggesting better nonoperative outcomes.

Nonoperative management is possible in up to half of patients with rectal cancer, revealing significant shifts in treatment strategies.
Adopting immunotherapy has shown promise in improving survival rates for patients with mismatch repair-deficient tumors.
Assessment highlights insights from landmark studies that have advanced the treatment paradigm for rectal cancer.
Future research efforts focus on optimizing therapies to enhance patient quality of life and survival outcomes.

Wheless et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark